K. Gunn
Pfizer (United Kingdom)(GB)
Publications by Year
Research Areas
Treatment of Major Depression, Schizophrenia research and treatment, Electroconvulsive Therapy Studies, Bipolar Disorder and Treatment, Neurotransmitter Receptor Influence on Behavior
Most-Cited Works
- → Comparison of Methods for Analysis of Clinical [11C]Raclopride Studies(1996)460 cited
- → Dose dependent occupancy of central dopamine D2 receptors by the novel neuroleptic CP-88,059-01: a study using positron emission tomography and11C-raclopride(1993)100 cited
- → The time course of binding to striatal dopamine D2 receptors by the neuroleptic ziprasidone (CP-88,059-01) determined by positron emission tomography(1996)85 cited
- → A double-blind placebo-controlled multicentre study of sertraline in the acute and continuation treatment of major depression(1997)26 cited
- → Intramuscular (IM) ziprasidone vs. IM haloperidol in patients with acute, non-organic psychosis(1998)6 cited
- → EFFECT OF SERTRALINE ON THE PHARMACOKINETICS OF ORAL HYPOGLYCEMIC AGENTS IN HEALTHY VOLUNTEERS(1992)2 cited
- → Un estudio multicéntrico doble ciego controlado con placebo de sertralina en el tratamiento agudo y de continuación de la depresión mayor(1997)